Treatment outcome with mTOR inhibitors for metastatic renal cell carcinoma with nonclear and sarcomatoid histologies

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Phase II trial of everolimus for the treatment of nonclear-cell renal cell carcinoma

(2012) Y. Koh et al.   ANNALS OF ONCOLOGY

Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma

(2012) Brian Shuch et al.   BJU INTERNATIONAL

Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: Analysis of response and progression-free survival in the RECORD-1 study

(2012) Stéphane Oudard et al.   EUROPEAN JOURNAL OF CANCER

Temsirolimus in renal cell carcinoma with sarcomatoid differentiation: a report of three cases

(2011) Maria Carmen Areses et al.   MEDICAL ONCOLOGY

Sarcomatoid-variant Renal Cell Carcinoma

(2010) Ana M. Molina et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Effect of temsirolimus versus interferon-α on outcome of patients with advanced renal cell carcinoma of different tumor histologies

(2009) Janice P. Dutcher et al.   MEDICAL ONCOLOGY

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Therapy

(2008) Ali Reza Golshayan et al.   JOURNAL OF CLINICAL ONCOLOGY